South and Central America Protein Expression Market Segments and Growth by 2028

The protein expression market in South and Central America is expected to grow from US$ 91.5 million in 2021 to US$ 158.8 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2021 to 2028.

The rising incidence of chronic diseases and increasing advancements in the biopharmaceutical industry are projected to drive the demand for protein expression techniques in the coming years. In addition, advancements in bioprocessing technologies have favoured the adoption of protein expression, which has further increased the use of recombinant proteins in therapeutics. According to a white paper article, “Recombinant Proteins for Industrial versus Pharmaceutical Purposes: A Review of Process and Pricing,” published in 2019, over 170 recombinant proteins are used for therapeutic purposes across the world, and the number of such recombinant proteins is expected to rise in the future. The production of recombinant protein is a complex, multidisciplinary, and expensive process, and hence it is not yet widely adopted. However, growing awareness has increased the demand for these proteins for human therapeutics. Also, the ongoing developments and evolving healthcare sector are expected to bring advancements in the process of producing recombinant proteins at affordable prices. Furthermore, commercial players seek opportunities to adopt easier, simpler, and automated methods for product development. Therefore, they are continuously striving to develop therapeutic products through economic processes to serve a large population. 

COVID-19 pandemic has become the most significant challenge in the region. However, demand for protein expression systems in this pandemic is inclined from the outbreak of Covid-19, but now the pharma companies are working on developing strategies to develop and manufacture the required reagents, instruments for the research of vaccine fulfill the demands of protein expression. The demand of protein expression in the region is expected to increase due to the rising Covid-19 cases and other diseases such as cancer.  Similarly, Latin America is hit by the COVID-19 pandemic and thus has profound humanitarian, economic, and political consequences. South and Central America are among the regions with rising number of reported cases of COVID-19. They have responded to the situation by closing borders, ordering quarantines, and imposing a host of restrictions to keep people confined at home. The impact of the COVID19 pandemic on the regional protein expression market is moderate.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the protein expression market. The South and Central America protein expression market is expected to grow at a good CAGR during the forecast period.

South and Central America Protein Expression Market Segmentation

By Product

• Competent Cells
• Expression Vectors
• Reagents
• Instruments

By Services

• Antibody Development & Production
• Protein Expression & Production
• Hybridoma One-Stop Services
• Stable Cell Line Development
• Bioanalytical Assay Services

By Application

• Research
• Therapeutic
• Industrial

By End User

• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Academic Research Institutes
• Others

By Country

• South and Central America

  • Brazil
  • Argentina
  • Rest of South and Central America

Companies Mentioned

• Thermo Fisher Scientific Inc.
• GenScript
• Merck KGaA
• Agilent Technologies, Inc.
• Takara Bio Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN
• New England Biolabs
• Promega Corporation

South and Central America Protein Expression Report Scope